8 research outputs found

    Efficacy of a Self-monitoring Traffic Light for Weight Control in Patients with Heart Failure in a Telerehabilitation Program

    Get PDF
    Heart Failure (HF), a life-threatening condition, poses a significant global health challenge. Monitoring patients’ symptoms and weight is essential, as key HF symptoms tend to cause weight gain and indicate decompensation. The aim of this study is to evaluate the effect of a traffic light algorithm on home monitoring of weight in HF patients. In the project ‘Future Patient – Telerehabilitation of Patients with HF II’, HF patients monitored their weight, blood pressure, pulse, steps, and sleep at home. Data has been transmitted to the web portal HeartPortal. Each measurement in the weight overview was color-coded using a traffic light algorithm that would indicate whether the patient’s weight changes were within the acceptable range. The patients’ monitoring data, along with their questionnaire responses, were then analyzed and interpreted. The analysis of the data suggests that the traffic light was effective in alerting patients to weight changes according to clinical guidelines. Most of the patients noticed the traffic light and understood the significance of the colors. The study demonstrates that the traffic light is an effective tool for alerting HF patients to weight fluctuations. The traffic light provides early warnings, enabling timely interventions, and encouraging patient engagement in understanding the causes behind weight changes

    Future Patient-Telerehabilitation of Patients With Atrial Fibrillation:Protocol for a Multicenter, Mixed Methods, Randomized Controlled Trial

    Get PDF
    Background: Atrial fibrillation (AF) is a chronic cardiovascular condition with a lifetime risk of 1 in 3 and a prevalence of 3% among adults. AF’s prevalence is predicted to more than double during the next 20 years due to better detection, increasing comorbidities, and an aging population. Due to increased AF prevalence, telerehabilitation has been developed to enhance patient engagement, health care accessibility, and compliance through digital technologies. A telerehabilitation program called “Future Patient—telerehabilitation of patients with AF (FP-AF)” has been developed to enhance rehabilitation for AF. The FP-AF program comprises two modules: (1) an education and monitoring module using telerehabilitation technologies (4 months) and (2) a follow-up module, where patients can measure steps and access a data and knowledge-sharing portal, HeartPortal, using their digital devices. Those patients in the FP-AF program measure their heart rhythm, pulse, blood pressure, weight, steps, and sleep. Patients also complete web-based questionnaires regarding their well-being and coping with AF. All recorded data are transmitted to the HeartPortal, accessible to patients, relatives, and health care professionals. Objective: This paper aims to describe the research design, outcome measures, and data collection techniques in a clinical trial of the FP-AF program for patients with AF. Methods: This is a multicenter, mixed methods, randomized controlled trial. Patients are recruited from AF clinics serving the North Jutland region of Denmark. The telerehabilitation group will participate in the FP-AF program, while the control group will follow the conventional care regime based on physical visits to the AF clinic. The primary outcome measure is AF-specific health-related quality of life, to be assessed using the Atrial Fibrillation Effect on Quality-of-Life Questionnaire. Secondary outcomes are knowledge of AF; measurement of vital parameters; level of anxiety and depression; degree of motivation; burden of AF; use of the HeartPortal; qualitative exploration of patients’, relatives’, and health care professionals’ experiences of participating in the FP-AF program; cost-effectiveness evaluation of the program; and analysis of multiparametric monitoring data. Outcomes are assessed through data from digital technologies, interviews, and questionnaires. Results: Patient enrollment began in January 2023 and will be completed by December 2024, with a total of 208 patients enrolled. Qualitative interviews conducted in spring 2024 will be analyzed and published in peer-reviewed journals in 2025. Data from questionnaires and digital technologies will be analyzed upon study completion and presented at international conferences and published in peer-reviewed journals by the fall of 2025. Conclusions: Results from the FP-AF study will determine whether the FP-AF program can increase quality of life for patients with AF and increase their knowledge of symptoms and living with AF in everyday life compared to conventional AF care. The cost-effectiveness evaluation will determine whether telerehabilitation can be a viable alternative for rehabilitation of patients with AF.</p

    Patient Perspectives on the 'Future Patient' Telerehabilitation Program for Atrial Fibrillation:Qualitative Study

    Get PDF
    Background: Atrial fibrillation (AF) is a prevalent chronic condition with increasing incidence worldwide. AF increases the risks of stroke, heart failure, and myocardial infarction and imposes a substantial burden on the health care system. Cardiac rehabilitation programs, while effective, often have low patient adherence. Recent evidence suggests that cardiac telerehabilitation, where patients are given home monitoring devices, could enhance adherence and outcomes. The program “Future Patient—Telerehabilitation of Patients with AF” (FP-AF) was created to assess the effects and potential benefits of cardiac telerehabilitation on patients with AF. Objective: The objective of this study is to explore the experiences of patients participating in the FP-AF program. Methods: This qualitative sub-study is part of the multicenter, randomized controlled FP-AF trial, which included 208 patients. Semi-structured interviews were conducted on 14 patients, randomly selected from participants in the intervention arm of the FP-AF program. The patient interviews, guided by self-determination theory, focused on patients’ experiences with the FP-AF program, including the use of telerehabilitation technologies and a web-based portal called the “HeartPortal.” Interview responses were analyzed using NVivo software (version 14.0; QSR International), with thematic coding based on interview guides and methodological guidance elaborated by Brinkmann &amp; Kvale. The study adhered to ethical guidelines, with informed consent obtained from all participants. Results: Based on the interviews, the following themes were identified: the home monitoring devices are viewed positively by the patients; the HeartPortal is a useful digital toolbox; patients develop new coping strategies for living with AF; the measured values are useful for the patients; the community of practice is beneficial; and the FP-AF program creates a sense of security. Conclusions: Participation in the FP-AF program enhanced patients’ sense of security, empowerment, and knowledge about AF. This improvement was due largely to a combination of patients’ use of the HeartPortal and the educational sessions at health care centers. Telerehabilitation for patients with AF may be a useful way of researching this group of patients with a focus on rehabilitation and may be an effective means of offering rehabilitation to this group in the future.</p

    Future Patient – Telerehabilitation of Patients with Atrial Fibrillation:Protocol for a Multicenter, Mixed methods, and Randomized Controlled Trial

    No full text
    Background:Atrial Fibrillation (AF) is a chronic cardiovascular condition with a lifetime risk of one in three, and a prevalence of 3% among adults. The prevalence of AF is predicted to more than double in the next 20 years due to better detection, increasing comorbidities, and an ageing population. Telerehabilitation has been developed to enhance patient’s engagement, healthcare accessibility, and compliance through digital technologies. A telerehabilitation program called ‘Future Patient’ has been developed for rehabilitation of AF patients. Future Patient consists of two modules: (1) an education and monitoring module using telerehabilitation technologies (4 months), and (2) a follow-up module, where patients can measure steps and access a data and knowledge-sharing portal, the HeartPortal, on their digital devices. Patients in the Future Patient Atrial Fibrillation (FP-AF) program measures their heart rhythm, pulse, blood pressure, weight, steps and sleep. They also complete online questionnaires regarding their well-being and coping with AF. All recorded data is transmitted to the HeartPortal, accessible to patients, relatives, and healthcare professionals.Objective:This paper aims to describe the research design, outcome measures, and data collection techniques in the clinical trial of the FP-AF Program for patients with AF.Methods:This is a multicenter, mixed methods, randomized controlled study. Patients are recruited from AF clinics. The telerehabilitation group will participate in the FP-AF program, while the control group will follow the conventional care regime based on physical visits to the AF clinic. The primary outcome measure is AF-specific health-related quality of life, to be assessed using the Atrial Fibrillation Effect on Quality-of-Life Questionnaire. Secondary outcomes are knowledge of AF; measurement of vital parameters; anxiety and depression; motivation; burden of AF; use of HeartPortal; qualitative exploration of patients’, relatives’, and health care professionals’ experiences of participating in the FP-AF program; cost-effectiveness evaluation of the program; and analysis of multiparametric monitoring-data. The outcomes are assessed through data from digital technologies and collected from interviews and questionnaires.Results:Enrollment of patients started in January 2023 and will be completed by December 2024, with a total of 208 patients enrolled. Qualitative interviews conducted in the spring of 2024 will be analyzed and published in peer reviewed journals in 2025. Data from questionnaires and digital technologies will be analyzed upon study completion and presented at international conferences and published in peer-reviewed journals by the fall of 2025.Conclusions:Results from the FP-AF study will explore whether the FP-AF program can increase quality of life for AF patients and increase their knowledge of symptoms and living with AF in everyday life. The cost-effectiveness evaluation will evaluate whether telerehabilitation can be a viable alternative for rehabilitation of AF patients. Clinical Trial: Clinicaltrials.gov NCT06101485, registered on June 26th, 2023. Approved by The North Denmark Region Committee on Health Research Ethics N-20220056
    corecore